Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 160.00% | -- | -81.09% | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 160.00% | -- | -81.09% | -100.00% |
| Cost of Revenue | -24.31% | -- | -23.49% | -11.25% | 18.56% |
| Gross Profit | 25.59% | 160.00% | 28.08% | -0.52% | -20.50% |
| SG&A Expenses | -10.06% | -4.00% | 3.11% | 4.12% | 1.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.83% | -21.35% | -15.87% | -6.47% | -6.66% |
| Operating Income | 32.10% | 21.97% | 19.15% | -1.76% | 2.56% |
| Income Before Tax | -1.72% | -16.69% | 20.24% | 21.46% | 34.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.72% | -16.69% | 20.24% | 21.46% | 34.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.72% | -16.69% | 20.24% | 21.46% | 34.68% |
| EBIT | 32.10% | 21.97% | 19.15% | -1.76% | 2.56% |
| EBITDA | 32.07% | 21.97% | 19.17% | -1.86% | 2.23% |
| EPS Basic | 68.22% | 81.45% | 87.37% | 85.95% | 85.90% |
| Normalized Basic EPS | 68.22% | 81.45% | 87.37% | 85.94% | 85.90% |
| EPS Diluted | 68.22% | 81.45% | 87.37% | 85.93% | 85.90% |
| Normalized Diluted EPS | 68.22% | 81.45% | 87.37% | 85.94% | 85.90% |
| Average Basic Shares Outstanding | 220.05% | 529.08% | 531.73% | 458.86% | 363.29% |
| Average Diluted Shares Outstanding | 220.05% | 529.08% | 531.73% | 458.86% | 363.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |